Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;3(5):371-380.
doi: 10.1038/s41551-019-0378-3. Epub 2019 Apr 1.

Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging

Affiliations

Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging

Kevin E Lindsay et al. Nat Biomed Eng. 2019 May.

Abstract

Visualization of the spatio-temporal trafficking of vaccines after their delivery would help evaluate the efficacy of candidate formulations and aid their rational design for preclinical and translational studies. Here, we show that a dual radionuclide-near-infrared probe allows for quantitative, longitudinal and non-invasive monitoring, via positron emission tomography-computed tomography and near-infrared imaging of cynomolgus macaques, of the trafficking dynamics to draining lymph nodes of a model messenger RNA vaccine labelled with the probe. After intramuscular administration of the vaccine to the monkeys, we observed the dynamics of the mRNA vaccine at the injection site and in the draining lymph nodes, performed cellular analyses of the involved tissues using flow cytometry and identified through immunofluorescence that professional antigen-presenting cells are the primary cells containing the injected mRNA and encoding the antigen. This approach may reveal spatio-temporal determinants of vaccine efficacy in preclinical and translational studies employing large mammals.

PubMed Disclaimer

Comment in

References

    1. Qin, L., Gilbert, P. B., Corey, L., McElrath, M. J. & Self, S. G. A framework for assessing immunological correlates of protection in vaccine trials. J. Infect. Dis. 196, 1304–1312 (2007). - DOI
    1. Gilbert, P. B., Qin, L. & Self, S. G. Evaluating a surrogate endpoint at three levels, with application to vaccine development. Stat. Med. 27, 4758–4778 (2008). - DOI
    1. DeFrancesco, L. The ‘anti-hype’ vaccine. Nat. Biotechnol. 35, 193–197 (2017). - DOI
    1. Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 12, 509–517 (2011). - DOI
    1. Verbeke, R. et al. Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: restoring the immunogenicity of immunosilent mRNA. J. Control. Release 266, 287–300 (2017). - DOI

Publication types

LinkOut - more resources